B. Riley Wealth Advisors Inc. Sells 1,545 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

B. Riley Wealth Advisors Inc. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,921 shares of the medical equipment provider’s stock after selling 1,545 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in Intuitive Surgical were worth $1,997,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in ISRG. Baystate Wealth Management LLC raised its stake in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares during the last quarter. MCF Advisors LLC increased its holdings in shares of Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 40 shares during the period. Headinvest LLC acquired a new position in shares of Intuitive Surgical during the third quarter valued at about $28,000. Able Wealth Management LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Finally, Stone House Investment Management LLC grew its position in Intuitive Surgical by 100.0% during the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 50 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on the company. Robert W. Baird cut their price target on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a report on Friday, April 19th. The Goldman Sachs Group started coverage on Intuitive Surgical in a research note on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price for the company. Citigroup lifted their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. StockNews.com cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Finally, Piper Sandler lifted their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday, April 19th. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $403.67.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $435.00 on Wednesday. The business has a fifty day moving average of $394.44 and a 200-day moving average of $376.56. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $436.94. The firm has a market cap of $154.29 billion, a PE ratio of 78.52, a price-to-earnings-growth ratio of 5.50 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the company posted $1.00 EPS. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 175 shares of the company’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00. Following the transaction, the senior vice president now owns 883 shares of the company’s stock, valued at $343,628.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the sale, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 175 shares of the stock in a transaction on Monday, May 13th. The shares were sold at an average price of $389.16, for a total value of $68,103.00. Following the completion of the transaction, the senior vice president now directly owns 883 shares in the company, valued at approximately $343,628.28. The disclosure for this sale can be found here. Insiders sold 17,956 shares of company stock worth $6,927,011 in the last quarter. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.